Match tier
Listed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-08-18
E
Emily Ward Bivens
Researcher
Also affiliated: University of Tennessee at Knoxville (2025)
Graduate Student Researcher
1 h-index
3 pubs
1 cited
Research Areas
Biography and Research Information
OverviewAI-generated summary
Emily Ward Bivens' research portfolio includes work in feminist literary criticism and clinical trial research. Her publications explore themes of gender and narrative representation, as seen in "Destabilizing the Legacies of Eggsplaining: A Feminist Reading of Humpty Dumpty." Concurrently, Bivens has contributed to clinical research, including a Phase I/II trial investigating a therapeutic vaccine for reducing head and neck cancer recurrence. This work involves collaboration with researchers at the University of Arkansas for Medical Sciences, including David W. Ussery, Jennifer L. Faulkner, Yong‐Chen Lu, and Jumin Sunde. Bivens' scholarly output, while currently modest with an h-index of 1 and three publications, indicates engagement in both humanities and health sciences research.
Metrics
- h-index: 1
- Publications: 3
- Citations: 1
Selected Publications
-
A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence (2026)
Collaboration Network
Top Collaborators
Omar Atiq
University of Arkansas for Medical Sciences
1 shared publication
In database
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
Teresa Evans
University of Arkansas for Medical Sciences
1 shared publication
In database
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
Ginger Brown
Winthrop Rockefeller Foundation
1 shared publication
In database
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
Jasmine Crane
University of Arkansas for Medical Sciences
1 shared publication
In database
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
Nadia Darwish
University of Arkansas for Medical Sciences
1 shared publication
In database
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
Jennifer L. Faulkner
Winthrop Rockefeller Foundation
1 shared publication
In database
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
Rangaswamy Govindarajan
University of Arkansas for Medical Sciences
1 shared publication
In database
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
Aaron Johnson
Winthrop Rockefeller Foundation
1 shared publication
In database
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
Alongkorn Kurilung
University of Arkansas for Medical Sciences
1 shared publication
In database
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
Oxana P. Lazarenko
University of Arkansas for Medical Sciences
1 shared publication
In database
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
Yong-Chen William Lu
University of Arkansas for Medical Sciences
1 shared publication
In database
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
Keanna Marsh
University of Arkansas for Medical Sciences
1 shared publication
In database
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
M Moreno
University of Arkansas for Medical Sciences
1 shared publication
In database
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
Intawat Nookaew
University of Arkansas for Medical Sciences
1 shared publication
In database
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
Michael Robeson
University of Arkansas for Medical Sciences
1 shared publication
In database
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
Similar Researchers
Based on overlapping research topics
Andrew A. Taylor
Arkansas Tech University
Cancer Treatment and Pharmacology
Race, History, and American Society
Media Studies and Communication
Aaron Johnson
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Head and Neck Cancer Studies
Vaccine Coverage and Hesitancy
Mindy Wilman
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Head and Neck Cancer Studies
Vaccine Coverage and Hesitancy
Teresa Evans
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Head and Neck Cancer Studies
Vaccine Coverage and Hesitancy
Keanna Marsh
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Head and Neck Cancer Studies
Vaccine Coverage and Hesitancy
Jennifer L. Faulkner
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Head and Neck Cancer Studies
Vaccine Coverage and Hesitancy